To date, NF1-associated HGG is incurable with a 5-year overall survival of 5%, despite advances in neurosurgical, radiation and chemotherapeutic approaches [7], highlighting the need to develop effective therapies for NF1 patients with HGG. This evidence concerns the gene NF1 and neurofibromatosis type 1.